Abstract:Numerous studies have demonstrated that microRNAs (miRNAs) play vital roles in papillary thyroid carcinoma (PTC). The aim of the present study was to examine the expression levels of miR-183 in PTC and investigate whether its potential roles involved targeting the programmed cell death 4 (PDCD4). Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to examine the expression levels of miR-183 in 38 PTC specimens and 4 PTC cell lines. MIT, colony formation, wound-healing and Transwell invasion assays, and flow cytometry were conducted to explore the potential functions of miR-183 in human TPC1 papillary thyroid carcinoma cells. The dual-luciferase reporter assay was performed to validate whether PDCD4 was a direct target of miR-183. The effects of modulating miR-183 on endogenous levels of PDCD4 were subsequently confirmed via RT-qPCR and western blotting. Functional assays were used to indicate the roles of endogenous PDCD4 in TPC1. The results showed the miR-183 expression levels were significantly upregulated in PTC specimens and cell lines (P<0.05). Overexpression of miR-183 in TPC1 promoted cell proliferation, migration, invasion and decreased apoptosis. The dual-luciferase reporter assay confirmed that PDCD4 was a direct target of miR-183. RT-qPCR and western blotting showed that miR-183 negatively regulated PDCD4 protein expression but had no impact on mRNA expression of PDCD4. Knockdown of PDCD4 expression in TPC1 cells significantly enhanced cell proliferation, migration, invasion and inhibited apoptosis. The results of the present study suggested that miR-183 acts as a papillary thyroid carcinoma oncogene through the negative regulation of PDCD4 protein expression at the post-transcriptional levels. Therefore, targeting miR-183 provides a novel strategy for the diagnosis and treatment of patients with PTC.

The tumor-promoting function of ECRG4 in papillary thyroid carcinoma and its related mechanism

ECRG4 Acts As a Tumor Suppressor Gene Frequently Hypermethylated in Human Breast Cancer.

[Expression and Function of ECRG4 in Hepatocellular Carcinoma].

CRMP4 Suppresses Cervical Cancer Cell Proliferation and EMT Through the Wnt/β-catenin Pathway

Expression of ECRG4, a Novel Esophageal Cancer-Related Gene, Downregulated by CpG Island Hypermethylation in Human Esophageal Squamous Cell Carcinoma

Transmembrane protease serine 4 promotes thyroid cancer proliferation via CREB phosphorylation.

Promoter methylation of esophageal cancer-related gene 4 in gastric cancer tissue and its clinical significance.

ECRG4 As a Novel Tumor Suppressor Gene Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo

ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma

ECRG4 Inhibits Growth and Invasiveness of Squamous Cell Carcinoma of the Head and Neck in Vitro and in Vivo

CXCR4 promotes migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma by activating STAT3 signaling pathway

SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition Via Wnt/β-Catenin Pathway

Overexpression of ECRG4 Enhances Chemosensitivity to 5-Fluorouracil in the Human Gastric Cancer SGC-7901 Cell Line

Downregulated ECRG4 is Associated with Poor Prognosis in Renal Cell Cancer and is Regulated by Promoter DNA Methylation

Integrin Β4 Promotes Invasion and Anoikis Resistance of Papillary Thyroid Carcinoma and is Consistently Overexpressed in Lymphovascular Tumor Thrombus

A potential role of human esophageal cancer-related gene-4 in cardiovascular homeostasis

TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway

ECRG4: a New Potential Target in Precision Medicine

Mir-183 Regulates Biological Behavior in Papillary Thyroid Carcinoma by Targeting the Programmed Cell Death 4.

Decreased sirtuin 4 levels promote cellular proliferation and invasion in papillary thyroid carcinoma

The Involvement of CXCR7 in Modulating the Progression of Papillary Thyroid Carcinoma.